How AI and LLMs are transforming drug discovery: part 1
AI is reshaping drug discovery – but not without resistance.…
AI is reshaping drug discovery – but not without resistance. In this two-part conversation, André França and Eli Pollock share honest insights about the real barriers to AI adoption in life sciences and how embedding domain expertise into AI workflows might be the key to unlocking its full potential.